Business Context and Reporting Period
Mustang Bio, Inc. filed this Form 8-K on October 25, 2016, to report the completion of the second closing of a private placement transaction previously announced on October 6, 2016. The company is a Delaware corporation headquartered in New York.
Key Financial Metrics
This filing details a capital raise event rather than operational financial performance. Key metrics from this specific transaction include:
- Gross Proceeds: $7,088,770
- Securities Issued: 109.058 Units
- Common Stock Issued: 1,090,580 shares
- Warrants Issued to Investors: 272,645 shares (exercisable at $8.50/share)
- Placement Agent Fee: $708,877 cash plus a warrant for 109,058 shares
The filing text does not provide clear values for revenue, profit, operating cash flow, margins, or total debt levels as this is a transaction-specific report.
Material Changes
The primary material change is the increase in the company's cash liquidity and share count resulting from the second closing of the private placement. This transaction adds to the capital raised in the first closing reported in the Prior 8-K.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or specific risk factors beyond standard securities law disclosures. It notes that the securities were sold pursuant to exemptions under Section 4(a)(2) and Rule 506 of Regulation D and that shares may not be resold in the U.S. absent registration or an applicable exemption.
Investor Verification Checklist
- Verify the total aggregate proceeds from both the first and second closings of the private placement.
- Confirm the total number of outstanding shares and warrants post-transaction.
- Review the full terms of the Purchase Agreements and Warrants in the upcoming Form 10-Q for the quarter ended September 30, 2016.
- Assess the impact of the placement agent fees and warrants on overall dilution.